Published in Br J Clin Pharmacol on August 01, 2010
Morphine versus oxycodone analgesia after percutaneous kidney stone surgery: a randomised double blinded study. Urolithiasis (2013) 1.26
Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev (2012) 1.25
Use of oxycodone in pain management. Anesth Pain Med (2012) 0.91
Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain. Br J Pharmacol (2011) 0.90
Drug management of visceral pain: concepts from basic research. Pain Res Treat (2012) 0.90
Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol (2013) 0.88
Human models of hyperalgesia and pain (chilli pepper with your acid indigestion, Sir?). Br J Clin Pharmacol (2010) 0.81
Sensitivity of quantitative sensory models to morphine analgesia in humans. J Pain Res (2014) 0.80
Gender, variation in opioid receptor genes and sensitivity to experimental pain. Mol Pain (2013) 0.79
Present-day challenges and future solutions in postoperative pain management: results from PainForum 2014. J Pain Res (2016) 0.77
Cingulate metabolites during pain and morphine treatment as assessed by magnetic resonance spectroscopy. J Pain Res (2014) 0.75
Effects of Short-Term Oxycodone Maintenance on Experimental Pain Responses in Physically Dependent Opioid Abusers. J Pain (2017) 0.75
Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain (2005) 13.45
Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer (2001) 3.40
The treatment of cancer pain. N Engl J Med (1985) 2.71
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain (2000) 1.97
Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology (2007) 1.93
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol (1998) 1.88
Peripheral mechanisms of opioid analgesia. Anesth Analg (1993) 1.81
Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain (2001) 1.71
Gut sensations in diabetic autonomic neuropathy. Pain (2007) 1.53
Experimental human pain models: a review of standardised methods for preclinical testing of analgesics. Basic Clin Pharmacol Toxicol (2004) 1.48
Oxycodone. J Pain Symptom Manage (2005) 1.44
The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain (1997) 1.42
Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil (2004) 1.40
The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol (1992) 1.40
Peak plasma concentrations after oral morphine: a systematic review. J Pain Symptom Manage (1998) 1.38
Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther (1990) 1.36
Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol Motil (2007) 1.32
Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacology (Berl) (2007) 1.29
Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Res (1988) 1.28
Computer-controlled pneumatic pressure algometry--a new technique for quantitative sensory testing. Eur J Pain (2001) 1.28
A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain (2006) 1.23
Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol (2004) 1.22
Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review. Br J Clin Pharmacol (2009) 1.22
Experimental pain in gastroenterology: a reappraisal of human studies. Scand J Gastroenterol (2003) 1.21
Oxycodone: a review of its use in the management of pain. Curr Med Res Opin (2008) 1.20
Pain in chronic pancreatitis: the role of neuropathic pain mechanisms. Gut (2008) 1.17
Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol (2007) 1.17
Central hypersensitivity in chronic pain: mechanisms and clinical implications. Phys Med Rehabil Clin N Am (2006) 1.17
Effects of kappa opioids in the inflamed rat colon. Pain (1999) 1.15
Multi-modal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics. Basic Clin Pharmacol Toxicol (2006) 1.15
Spinal mechanisms underlying persistent pain and referred hyperalgesia in rats with an experimental ureteric stone. J Neurophysiol (1998) 1.13
Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization. Mol Pharmacol (2008) 1.13
Referred muscle pain: basic and clinical findings. Clin J Pain (2001) 1.12
Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol (2007) 1.09
Multimodal assessment of pain in the esophagus: a new experimental model. Am J Physiol Gastrointest Liver Physiol (2002) 1.08
No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer (2005) 1.08
Multi-modal induction and assessment of allodynia and hyperalgesia in the human oesophagus. Eur J Pain (2003) 1.05
A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy. Anesth Analg (2009) 1.04
Human experimental pain models in drug development: translational pain research. Curr Opin Investig Drugs (2007) 1.04
Visceral pain-central sensitisation. Gut (2000) 1.03
How different is oxycodone from morphine? Pain (2007) 1.02
Computerized cuff pressure algometry: A new method to assess deep-tissue hypersensitivity in fibromyalgia. Pain (2007) 1.01
Spinal opioid systems in inflammation. Inflamm Res (1995) 0.98
Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Anesthesiology (2008) 0.94
Central sensitization in patients with non-cardiac chest pain: a clinical experimental study. Scand J Gastroenterol (2006) 0.94
Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol (1993) 0.92
The expression of delta- and kappa-opioid receptor is enhanced during intestinal inflammation in mice. J Pharmacol Exp Ther (2003) 0.91
Morphine or oxycodone in cancer pain? Acta Oncol (2000) 0.91
Multimodal pain stimulations in patients with grade B oesophagitis. Gut (2005) 0.89
Inflammation enhances mu-opioid receptor transcription and expression in mice intestine. Mol Pharmacol (2001) 0.89
Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial. Jpn J Clin Oncol (2008) 0.88
Characterization of sensations induced by capsaicin in the upper gastrointestinal tract. Neurogastroenterol Motil (2007) 0.87
Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol (1999) 0.87
Characterization of the antinociceptive effect of oxycodone in male and female rats. Pharmacol Biochem Behav (2006) 0.87
Cortical changes to experimental sensitization of the human esophagus. Neuroscience (2006) 0.86
Volunteer studies in pain research--opportunities and challenges to replace animal experiments: the report and recommendations of a Focus on Alternatives workshop. Neuroimage (2008) 0.84
Dissociation of morphine analgesia and sedation evaluated by EEG measures in healthy volunteers. Arzneimittelforschung (2004) 0.84
An experimental study of viscero-visceral hyperalgesia using an ultrasound-based multimodal sensory testing approach. Pain (2005) 0.84
Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model. J Clin Pharmacol (2008) 0.84
Evoked human oesophageal hyperalgesia: a potential tool for analgesic evaluation? Basic Clin Pharmacol Toxicol (2009) 0.83
Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification - evidence of central sensitization. Neurogastroenterol Motil (2007) 0.83
Perceptual wind-up in the human oesophagus is enhanced by central sensitisation. Gut (2006) 0.82
Central pain mechanisms following combined acid and capsaicin perfusion of the human oesophagus. Eur J Pain (2009) 0.81
Characterization of the antinociceptive effects of oxycodone in diabetic mice. Eur J Pharmacol (2006) 0.81
Statistical modeling of the response characteristics of mechanosensitive stimuli in the human esophagus. J Pain (2005) 0.80
Antinociceptive effect of oxycodone in diabetic mice. Eur J Pharmacol (2005) 0.79
Steady-state kinetics and dynamics of morphine in cancer patients: is sedation related to the absorption rate of morphine? J Pain Symptom Manage (1999) 0.76
Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med (2011) 8.62
A Randomized, Controlled Trial of Total Knee Replacement. N Engl J Med (2015) 7.00
Studying sex and gender differences in pain and analgesia: a consensus report. Pain (2007) 3.58
Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain (2010) 2.16
Myofascial trigger points in patients with whiplash-associated disorders and mechanical neck pain. Pain Med (2014) 2.00
Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology (2007) 1.93
Descending inhibitory pain modulation is impaired in patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2010) 1.80
Age effects on pain thresholds, temporal summation and spatial summation of heat and pressure pain. Pain (2005) 1.62
Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol (2010) 1.59
The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J Pain (2009) 1.57
Reduced cortical thickness of brain areas involved in pain processing in patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2011) 1.54
Gut sensations in diabetic autonomic neuropathy. Pain (2007) 1.53
Altered brain microstructure assessed by diffusion tensor imaging in patients with chronic pancreatitis. Gut (2011) 1.53
Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain (2004) 1.52
Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients. Pain (2011) 1.49
Experimental human pain models: a review of standardised methods for preclinical testing of analgesics. Basic Clin Pharmacol Toxicol (2004) 1.48
Effect of low-level clenching and subsequent muscle pain on exteroceptive suppression and resting muscle activity in human jaw muscles. Clin Neurophysiol (2007) 1.46
Brain activity in rectosigmoid pain: unravelling conditioning pain modulatory pathways. Clin Neurophysiol (2011) 1.46
Exteroceptive aspects of nociception: insights from graphesthesia and two-point discrimination. Pain (2010) 1.46
Increased H-reflex response induced by intramuscular electrical stimulation of latent myofascial trigger points. Acupunct Med (2009) 1.44
Ranking of tests for pain hypersensitivity according to their discriminative ability in chronic neck pain. Reg Anesth Pain Med (2013) 1.40
Generalized deep-tissue hyperalgesia in patients with chronic low-back pain. Eur J Pain (2006) 1.35
Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology (2011) 1.34
Anticipatory cortical responses during the expectancy of a predictable painful stimulation. A high-resolution electroencephalography study. Eur J Neurosci (2003) 1.33
Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol (2003) 1.30
A comparative study of different references for EEG spectral mapping: the issue of the neutral reference and the use of the infinity reference. Physiol Meas (2005) 1.27
Morphine versus oxycodone analgesia after percutaneous kidney stone surgery: a randomised double blinded study. Urolithiasis (2013) 1.26
A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain (2006) 1.23
Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review. Br J Clin Pharmacol (2009) 1.22
Opioid-induced bowel dysfunction: pathophysiology and management. Drugs (2012) 1.22
Acidic buffer induced muscle pain evokes referred pain and mechanical hyperalgesia in humans. Pain (2008) 1.20
Postoperative hyperalgesia: its clinical importance and relevance. Anesthesiology (2006) 1.20
Oxycodone: a review of its use in the management of pain. Curr Med Res Opin (2008) 1.20
Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain (2009) 1.19
Sympathetic facilitation of hyperalgesia evoked from myofascial tender and trigger points in patients with unilateral shoulder pain. Clin Neurophysiol (2006) 1.18
Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs. Pharmacol Rev (2012) 1.17
Central hypersensitivity in chronic pain: mechanisms and clinical implications. Phys Med Rehabil Clin N Am (2006) 1.17
Bilateral widespread mechanical pain sensitivity in carpal tunnel syndrome: evidence of central processing in unilateral neuropathy. Brain (2009) 1.16
Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol (2009) 1.16
Endometriosis is associated with central sensitization: a psychophysical controlled study. J Pain (2003) 1.16
Inhibition of maximal voluntary contraction force by experimental muscle pain: a centrally mediated mechanism. Muscle Nerve (2002) 1.15
Factor analysis of responses to thermal, electrical, and mechanical painful stimuli supports the importance of multi-modal pain assessment. Pain (2011) 1.15
Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain (2003) 1.15
Comparison of glutamate-evoked pain between the temporalis and masseter muscles in men and women. Pain (2012) 1.15
Temporal summation of pain evoked by mechanical stimulation in deep and superficial tissue. J Pain (2005) 1.15
Spatial and temporal aspects of deep tissue pain assessed by cuff algometry. Pain (2002) 1.15
Multi-modal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics. Basic Clin Pharmacol Toxicol (2006) 1.15
The effect of reference choices on the spatio-temporal analysis of brain evoked potentials: the use of infinite reference. Comput Biol Med (2007) 1.14
Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain (2003) 1.14
Bilateral widespread mechanical pain sensitivity in women with myofascial temporomandibular disorder: evidence of impairment in central nociceptive processing. J Pain (2009) 1.13
Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol (2007) 1.09
Multimodal assessment of pain in the esophagus: a new experimental model. Am J Physiol Gastrointest Liver Physiol (2002) 1.08
Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg (2003) 1.07
Pressure-pain function in desensitized and hypersensitized muscle and skin assessed by cuff algometry. J Pain (2002) 1.07
The change in spatial distribution of upper trapezius muscle activity is correlated to contraction duration. J Electromyogr Kinesiol (2006) 1.06
Patients with chronic pain after abdominal surgery show less preoperative endogenous pain inhibition and more postoperative hyperalgesia: a pilot study. J Pain Palliat Care Pharmacother (2010) 1.06
Muscle trigger points and pressure pain hyperalgesia in the shoulder muscles in patients with unilateral shoulder impingement: a blinded, controlled study. Exp Brain Res (2010) 1.05
Reference values of mechanical and thermal pain tests in a pain-free population. Eur J Pain (2010) 1.05
Multi-modal induction and assessment of allodynia and hyperalgesia in the human oesophagus. Eur J Pain (2003) 1.05
Modulation of central hypersensitivity by nociceptive input in chronic pain after whiplash injury. Pain Med (2004) 1.05
Attenuated skin blood flow response to nociceptive stimulation of latent myofascial trigger points. Arch Phys Med Rehabil (2009) 1.03
Inward currents in primary nociceptive neurons of the rat and pain sensations in humans elicited by infrared diode laser pulses. Pain (2002) 1.03
Dispositional anxiety and the experience of pain: gender-specific effects. Eur J Pain (2003) 1.02
Pressure pain sensitivity maps of the neck-shoulder and the low back regions in men and women. BMC Musculoskelet Disord (2010) 1.01
Health related quality of life and quantitative pain measurement in females with chronic non-malignant pain. Eur J Pain (2005) 1.01
Anticipatory electroencephalography alpha rhythm predicts subjective perception of pain intensity. J Pain (2006) 1.01
Computerized cuff pressure algometry: A new method to assess deep-tissue hypersensitivity in fibromyalgia. Pain (2007) 1.01
Experimental muscle pain changes the spatial distribution of upper trapezius muscle activity during sustained contraction. Clin Neurophysiol (2006) 1.01
Is the pain in chronic pancreatitis of neuropathic origin? Support from EEG studies during experimental pain. World J Gastroenterol (2008) 1.00
Widespread mechanical pain hypersensitivity as sign of central sensitization in unilateral epicondylalgia: a blinded, controlled study. Clin J Pain (2009) 1.00
Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg (2008) 1.00
Lower mechanical pressure pain thresholds in female adolescents with patellofemoral pain syndrome. J Orthop Sports Phys Ther (2013) 1.00
Pathophysiology of chronic pancreatitis. World J Gastroenterol (2013) 0.99
Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain (2008) 0.99
Sensory and motor effects of experimental muscle pain in patients with lateral epicondylalgia and controls with delayed onset muscle soreness. Pain (2005) 0.99
Acid hypersensitivity in patients with eosinophilic oesophagitis. Scand J Gastroenterol (2010) 0.98
Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males. Exp Brain Res (2005) 0.98
Ranking of parameters of pain hypersensitivity according to their discriminative ability in chronic low back pain. Pain (2012) 0.98
The effects of intra-oral pain on motor cortex neuroplasticity associated with short-term novel tongue-protrusion training in humans. Pain (2007) 0.98
Standardising surface electromyogram recordings for assessment of activity and fatigue in the human upper trapezius muscle. Eur J Appl Physiol (2002) 0.98
Cognitive-emotional sensitization contributes to wind-up-like pain in phantom limb pain patients. Pain (2010) 0.97
Motor unit conduction velocity during sustained contraction after eccentric exercise. Med Sci Sports Exerc (2009) 0.97
Referred pain from trapezius muscle trigger points shares similar characteristics with chronic tension type headache. Eur J Pain (2006) 0.97
Changes in the degree of motor variability associated with experimental and chronic neck-shoulder pain during a standardised repetitive arm movement. Exp Brain Res (2007) 0.97
Enhanced temporal summation of pressure pain in the trapezius muscle after delayed onset muscle soreness. Exp Brain Res (2005) 0.97